Patent · US Active

Targeted immunotolerance

US10961310B2 · kind B2 · utility

4Cited by
108References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 15, 2018
Grant dateMar 30, 2021
Priority date—
Expiry dateMay 29, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/75
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods and compounds for conferring site-specific or local immune privilege.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.